Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: A comparative and a placebo-controlled multicenter study

International Urogynecology Journal

Volumn 10, Issue 3, 1999, Pages 171-176

  Casper, F ^a,b   Petri, E ^b,b,c   Almendral, C ^b   Distler, W ^b   Frick, J ^b   Herold, J ^b   Huenges, P ^b   Hussong, R ^b   Methfessel, H D ^b   Muller M ^b   Retzke, U ^b   Santellani, M ^b   Weise, W ^b   Wilhelm, H ^b   Wortmann, M ^b   Zimber, P ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Dept of Obstetrics and Gynecology ^*

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Estradiol; Local estriol therapy; Urogenital atrophy; Vaginal ring

Indexed keywords

ESTRADIOL; ESTRIOL; SILICONE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MASTALGIA; MATURATION; PH; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTAL DRUG ADMINISTRATION; SKIN IRRITATION; SUPPOSITORY; UROGENITAL TRACT DISEASE; VAGINA ATROPHY; VAGINA EPITHELIUM; VAGINA RING;

EID: 6544294653     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001920050040     Document Type: Article

References (15)

1. Contraception: Workshop Proceedings 1981;24:321-491
2. Englund DE, Victor A, Johansson EDB. Pharmacokinetics and pharmacodynamic effects of vaginal oestradiol administration from silastic rings in postmenopausal women. Maturitas 1981;3:125-133
3. Stumpf P, Maruca G, Santen R et al. Development of a vaginal ring for achieving physiological levels of 17 β-estradiol in hypoestrogenic women. J Clin Endocrinol Metab 1982;54:208-210
4. Veldhuis J, Samojlik E, Evans W. Endocrine impact of pure estradiol replacement in postmenopausal women: alterations in anterior pituitary hormone release and circulating sex steroid hormone concentrations. Am J Obstet Gynecol 1986;155:334-339
5. Holmgren PA, Lindskog M, von Schoultz B. Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophy. Maturitas 1989;11:55-63
6. Smith P, Heimer G, Lindskog M et al. Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy. Maturitas 1993;16:145-154
7. Hustin J, Van den Eynde JP. Cytologic evaluation of the effect of various estrogens given in postmenopause. Acta Cytol 1977;21:225-228
8. Barlow DH, Cardozo LD, Francis RM et al. Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol 1997;104:87-91
9. Iosif CS, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984;63:257-260
10. Iosif CS, Batra SC, Ek A et al. Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol 1981;141:817-820
11. Semmons JP, Wagner G. Estrogen deprivation and vaginal function in postmenopausal women. JAMA 1982;248:445-448
12. Privette M, Cade R, Peterson J et al. Prevention of recurrent urinary tract infections in postmenopausal women. Nephron 1988;50:24-27
13. Hennriksson L, Stjernquist M, Boquist L, Alander U, Selinus I. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol 1994;171:624-632
14. Henriksson L, Stjernquist M, Boquist L et al. A one-year multicenter study of efficacy and safety of a continuous low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging. Am J Obstet Gynecol 1996;174:85-92
15. Raz RW, Stamm WA. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infection. N Engl J Med 1993;329:753-756